Traws Pharma, Inc.
TRAW
$0.54
-$0.01-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 71.04% | -12.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -54.29% | -5.73% | |||
| Operating Income | 54.29% | 5.73% | |||
| Income Before Tax | 57.03% | 4.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 57.03% | 4.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 57.03% | 4.51% | |||
| EBIT | 54.29% | 5.73% | |||
| EBITDA | 54.64% | 5.76% | |||
| EPS Basic | 69.23% | 7.26% | |||
| Normalized Basic EPS | 71.18% | 16.03% | |||
| EPS Diluted | 69.23% | 7.26% | |||
| Normalized Diluted EPS | 71.18% | 16.03% | |||
| Average Basic Shares Outstanding | 49.09% | 13.70% | |||
| Average Diluted Shares Outstanding | 49.09% | 13.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||